C-MER Medical (03309) Issues Profit Alert, Expects First-Half Profit Attributable to Equity Holders of Approximately HK$46-52 Million, Up 49%-69% Year-on-Year
Stock News
Aug 19
C-MER Medical (03309) announced that the group expects to achieve profit attributable to equity holders of the company of approximately HK$46-52 million for the first half of 2025, representing an increase of approximately 49% to 69% compared to the same period last year.
The expected increase in profit attributable to company shareholders is primarily driven by revenue rising slightly from HK$922.5 million in the corresponding period last year to approximately HK$940 million in the first half of 2025. The improvement also benefits from the significant effectiveness of the company's strategies to optimize its service network and enhance operational efficiency, including closing underperforming businesses and implementing cost-saving measures.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.